New World Medical
Private Company
Funding information not available
Overview
New World Medical is a privately held, commercial-stage medical device company specializing in surgical glaucoma solutions. With a 35+ year legacy originating from the invention of the Ahmed Glaucoma Valve, the company has built a comprehensive portfolio of implantable devices and surgical systems. It operates with a distinct humanitarian-focused business model, measuring success by 'patients served' and dedicating 10% of profits to philanthropic efforts via the Sidra Tree Foundation. Its products are available in over 78 countries.
Technology Platform
Portfolio of implantable glaucoma drainage devices (valved and non-valved), minimally invasive glaucoma surgical (MIGS) tools, and surgical support systems for ophthalmic surgery.
Opportunities
Risk Factors
Competitive Landscape
Operates in the competitive surgical glaucoma device market against major players like Alcon (Cypass, now withdrawn, and other devices), Johnson & Johnson Vision (iStent), and Glaukos (iStent inject, iDose). Also competes with other MIGS and drainage device companies such as Santen, Sight Sciences, and Ivantis.